慶應義塾研究者情報データベース

経歴 【 表示 ／ 非表示 】

経歴 【 表示 ／ 非表示 】

• 2015年04月

  -

  継続中

  内科学教室、呼吸器内科, 助教

学歴 【 表示 ／ 非表示 】

学歴 【 表示 ／ 非表示 】

• 2005年03月

  昭和大学, 医学部

  大学

学位 【 表示 ／ 非表示 】

学位 【 表示 ／ 非表示 】

• 博士（医学）, 慶應義塾大学, 論文

  Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis　in Japanese patients with or at risk for COPD.

研究分野 【 表示 ／ 非表示 】

研究分野 【 表示 ／ 非表示 】

• ライフサイエンス / 呼吸器内科学

研究テーマ 【 表示 ／ 非表示 】

研究テーマ 【 表示 ／ 非表示 】

• COPD, 

  2009年04月

  -

  継続中

• 肺癌, 

  2009年04月

  -

  継続中

• 慢性閉塞性肺疾患, 

  2009年04月

  -

  継続中

著書 【 表示 ／ 非表示 】

著書 【 表示 ／ 非表示 】

• 呼吸器内科

  中鉢 正太郎, 科学評論社, 2013年06月

  担当範囲: 【COPDの併存症とその治療】 COPDと骨粗鬆症

• Medical Practice

  中鉢 正太郎, 文光堂, 2012年04月

  担当範囲: 【気管支喘息・実地診療の最前線】 セミナー/病態に基づく実地診療のポイント　喘息とCOPDの関連性と鑑別　診療上の相違点

• 呼吸器内科

  中鉢 正太郎, 科学評論社, 2011年09月

  担当範囲: COPDのバイオマーカー(解説)

論文 【 表示 ／ 非表示 】

論文 【 表示 ／ 非表示 】

• Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19

  Tanaka H., Chubachi S., Asakura T., Namkoong H., Azekawa S., Otake S., Nakagawara K., Fukushima T., Lee H., Watase M., Sakurai K., Kusumoto T., Masaki K., Kamata H., Ishii M., Hasegawa N., Okada Y., Koike R., Kitagawa Y., Kimura A., Imoto S., Miyano S., Ogawa S., Kanai T., Fukunaga K.

  BMC Infectious Diseases 24 （ 1 ）  2024年12月

  　概要を見る

  Background: Renal impairment is a predictor of coronavirus disease (COVID-19) severity. No studies have compared COVID-19 outcomes in patients with chronic kidney disease (CKD) and patients with impaired renal function without a prior diagnosis of CKD. This study aimed to identify the impact of pre-existing impaired renal function without CKD on COVID-19 outcomes. Methods: This retrospective study included 3,637 patients with COVID-19 classified into three groups by CKD history and estimated glomerular filtration rate (eGFR) on referral: Group 1 (n = 2,460), normal renal function without a CKD history; Group 2 (n = 905), impaired renal function without a CKD history; and Group 3 (n = 272), history of CKD. We compared the clinical characteristics of these groups and assessed the effect of CKD and impaired renal function on critical outcomes (requirement for respiratory support with high-flow oxygen devices, invasive mechanical ventilation, or extracorporeal membrane oxygen, and death during hospitalization) using multivariable logistic regression. Results: The prevalence of comorbidities (hypertension, diabetes, and cardiovascular disease) and incidence of inflammatory responses (white blood counts, and C-reactive protein, procalcitonin, and D-dimer levels) and complications (bacterial infection and heart failure) were higher in Groups 2 and 3 than that in Group 1. The incidence of critical outcomes was 10.8%, 17.7%, and 26.8% in Groups 1, 2, and 3, respectively. The mortality rate and the rate of requiring IMV support was lowest in Group 1 and highest in Group 3. Compared with Group 1, the risk of critical outcomes was higher in Group 2 (adjusted odds ratio [aOR]: 1.32, 95% confidence interval [CI]: 1.03–1.70, P = 0.030) and Group 3 (aOR: 1.94, 95% CI: 1.36–2.78, P < 0.001). Additionally, the eGFR was significantly associated with critical outcomes in Groups 2 (odds ratio [OR]: 2.89, 95% CI: 1.64–4.98, P < 0.001) and 3 (OR: 1.87, 95% CI: 1.08–3.23, P = 0.025) only. Conclusions: Clinicians should consider pre-existing CKD and impaired renal function at the time of COVID-19 diagnosis for the management of COVID-19.

  • Access to Document (DOI)

• Increased adiposity-to-muscle ratio and severity of sinusitis affect quality of life in asthma: Computed tomographic analysis

  Shimizu K., Kimura H., Tanabe N., Tanimura K., Chubachi S., Iijima H., Sato S., Wakazono N., Nakamaru Y., Okada K., Makita H., Goudarzi H., Suzuki M., Nishimura M., Konno S.

  Journal of Allergy and Clinical Immunology: Global 3 （ 3 ）  2024年08月

  　概要を見る

  Background: Deteriorated sinusitis and increased adiposity relative to muscle mass may affect quality of life in patients with asthma. However, whether these effects are observed regardless of intrapulmonary pathology is unknown. Objectives: We evaluated the correlation of the cross-sectional ratio of abdominal visceral fat (VF) to erector spinae muscle (ESM) and sinus findings based on Lund-Mackey scoring system (LMS) on computed tomography (CT) with the impaired score of the Asthma Quality of Life Questionnaire (AQLQ), regardless of airway and parenchymal disease, in patients with asthma. Methods: We recruited participants from the Hokkaido-based severe asthma cohort who had completed AQLQ and CT examination at the entry. The participants were divided into high (highest) and low (other quartiles) groups on the bases of the extrapulmonary indices. Multivariate analysis examined the association of VF/ESM for the adiposity-to-muscle ratio and LMS with AQLQ after adjusting for the airway fractal dimension for airway index and percentage of low attenuation volume to lung volume for parenchymal index. Results: No significant differences were observed in VF/ESM and LMS in terms of sex. The AQLQ score in the high VF/ESM group and high LMS group was lower than those in low VF/ESM group and low LMS group (63 male and 100 female subjects). High VF/ESM (estimate [95% confidence interval] (−0.43 [−0.61, −0.25]) and high LMS scores (−0.22 [−0.41, −0.03]) were associated with low AQLQ scores when adjusted for age, body mass index, smoking status, blood eosinophil count, and intrapulmonary CT indices. Conclusions: Increased VF relative to ESM mass and high LMS may deteriorate asthma-related quality of life, regardless of presence of intrapulmonary disease.

  • Access to Document (DOI)

• CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome

  Azekawa S., Maetani T., Chubachi S., Asakura T., Tanabe N., Shiraishi Y., Namkoong H., Tanaka H., Shimada T., Fukushima T., Otake S., Nakagawara K., Watase M., Terai H., Sasaki M., Ueda S., Kato Y., Harada N., Suzuki S., Yoshida S., Tateno H., Yamada Y., Jinzaki M., Hirai T., Okada Y., Koike R., Ishii M., Kimura A., Imoto S., Miyano S., Ogawa S., Kanai T., Fukunaga K.

  Bone 184 2024年07月

  ISSN  87563282

  　概要を見る

  The low vertebral bone computed tomography (CT) Hounsfield unit values measured on CT scans reflect low bone mineral density (BMD) and are known as diagnostic indicators for osteoporosis. The potential prognostic significance of low BMD defined by vertebral bone CT values for the coronavirus disease 2019 (COVID-19) remains unclear. This study aimed to assess the impact of BMD on the clinical outcome in Japanese patients with COVID-19 and evaluate the association between BMD and critical outcomes, such as high-flow nasal cannula, non-invasive and invasive positive pressure ventilation, extracorporeal membrane oxygenation, or death. We examined the effects of COVID-19 severity on the change of BMD over time. This multicenter retrospective cohort study enrolled 1132 inpatients with COVID-19 from the Japan COVID-19 Task Force database between February 2020 and September 2022. The bone CT values of the 4th, 7th, and 10th thoracic vertebrae were measured from chest CT images. The average of these values was defined as BMD. Furthermore, a comparative analysis was conducted between the BMD on admission and its value 3 months later. The low BMD group had a higher proportion of critical outcomes than did the high BMD group. In a subanalysis stratifying patients by epidemic wave according to onset time, critical outcomes were higher in the low BMD group in the 1st–4th waves. Multivariable logistic analysis of previously reported factors associated with COVID-19 severity revealed that low BMD, chronic kidney disease, and diabetes were independently associated with critical outcomes. At 3 months post-infection, patients with oxygen demand during hospitalization showed markedly decreased BMD than did those on admission. Low BMD in patients with COVID-19 may help predict severe disease after the disease onset. BMD may decrease over time in patients with severe COVID-19, and the impact on sequelae symptoms should be investigated in the future.

  • Access to Document (DOI)

• Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020–2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society

  Kamata H., Takamatsu K., Fukunaga K., Chubachi S., Nakagawara K., Namkoong H., Terai H., Tanaka K., Sato S., Hagiwara E., Takei R., Kondoh Y., Takazono T., Hashimoto M., Tasaka S., Ohrui T., Tanino Y., Mineshita M., Komase Y., Miyazaki K., Nishikawa M., Ando A., Kita H., Ichihara E., Ohshimo S., Murata Y., Ishida M., Kobayashi S., Uchida T., Tateno H., Ikari J., Terashima T., Kozu Y., Tateishi T., Shinkai M., Sagara H., To Y., Ito Y., Yamamoto M., Yamamoto Y., Kita T., Ito Y., Tomii K., Fujita Y., Funaki Y., Yatera K., Yamasue M., Komiya K., Kozawa S., Manabe H., Hozumi H., Horiguchi T., Kitajima T., Nakano Y., Nagaoka T., Hojo M., Ebihara A., Kobayashi M., Takayama K., Jinta T., Sawai T., Fukuda Y., Kaneko T., Chin K., Ogura T., Mukae H., Ishii M., Yokoyama A.

  Respiratory Investigation 62 （ 4 ） 572 - 579 2024年07月

  ISSN  22125345

  　概要を見る

  Background: No comprehensive analysis of the pulmonary sequelae of coronavirus disease 2019 (COVID-19) in Japan based on respiratory function tests and chest computed tomography (CT) has been reported. We evaluated post-COVID-19 conditions, especially focusing on pulmonary sequelae assessed by pulmonary function tests and chest CT. Methods: For this prospective cohort study, we enrolled 1069 patients who presented pneumonia at the time of admission in 55 hospitals from February 2020 to September 2021. Disease severity was classified as moderateⅠ, moderate II, and severe, defined primarily according to the degree of respiratory failure. The data on post-COVID-19 conditions over 12 months, pulmonary function, and chest CT findings at 3 months were evaluated in this study. Additionally, the impact of COVID-19 severity on pulmonary sequelae, such as impaired diffusion capacity, restrictive pattern, and CT abnormalities, was also evaluated. Results: The most frequently reported post-COVID-19 conditions at 3 months after COVID-19 were muscle weakness, dyspnea, and fatigue (48.4%, 29.0%, and 24.7%, respectively). The frequency of symptoms gradually decreased over subsequent months. In pulmonary function tests at 3 months, the incidence of impaired diffusion capacity and restrictive pattern increased depending on disease severity. There also were differences in the presence of chest CT abnormalities at the 3 months, which was markedly correlated with the severity. Conclusion: We reported a comprehensive analysis of post-COVID-19 condition, pulmonary function, and chest CT abnormalities in Japanese patients with COVID-19. The findings of this study will serve as valuable reference data for future post-COVID-19 condition research in Japan.

  • Access to Document (DOI)

• Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan

  Otake S., Shiraishi Y., Chubachi S., Tanabe N., Maetani T., Asakura T., Namkoong H., Shimada T., Azekawa S., Nakagawara K., Tanaka H., Fukushima T., Watase M., Terai H., Sasaki M., Ueda S., Kato Y., Harada N., Suzuki S., Yoshida S., Tateno H., Yamada Y., Jinzaki M., Hirai T., Okada Y., Koike R., Ishii M., Hasegawa N., Kimura A., Imoto S., Miyano S., Ogawa S., Kanai T., Fukunaga K.

  BMJ Open Respiratory Research 11 （ 1 ）  2024年04月

  　概要を見る

  Objective This study aimed to investigate the utility of CT quantification of lung volume for predicting critical outcomes in COVID-19 patients. Methods This retrospective cohort study included 1200 hospitalised patients with COVID-19 from 4 hospitals. Lung fields were extracted using artificial intelligence-based segmentation, and the percentage of the predicted (%pred) total lung volume (TLC (%pred)) was calculated. The incidence of critical outcomes and posthospitalisation complications was compared between patients with low and high CT lung volumes classified based on the median percentage of predicted TLCct (n=600 for each). Prognostic factors for residual lung volume loss were investigated in 208 patients with COVID-19 via a follow-up CT after 3 months. Results The incidence of critical outcomes was higher in the low TLCct (%pred) group than in the high TLCct (%pred) group (14.2% vs 3.3%, p<0.0001). Multivariable analysis of previously reported factors (age, sex, body mass index and comorbidities) demonstrated that CT-derived lung volume was significantly associated with critical outcomes. The low TLCct (%pred) group exhibited a higher incidence of bacterial infection, heart failure, thromboembolism, liver dysfunction and renal dysfunction than the high TLCct (%pred) group. TLCct (%pred) at 3 months was similarly divided into two groups at the median (71.8%). Among patients with follow-up CT scans, lung volumes showed a recovery trend from the time of admission to 3 months but remained lower in critical cases at 3 months. Conclusion Lower CT lung volume was associated with critical outcomes, posthospitalisation complications and slower improvement of clinical conditions in COVID-19 patients.

  • Access to Document (DOI)

全件表示 >>

KOARA（リポジトリ）収録論文等 【 表示 ／ 非表示 】

KOARA（リポジトリ）収録論文等 【 表示 ／ 非表示 】

• 喫煙誘導肺癌の発症における脂質メディエーターの役割の解明

  中鉢, 正太郎

  学事振興資金研究成果実績報告書 （慶應義塾大学)  2022年

• 喫煙誘導マウスモデルにおける肺がん発生機序

  中鉢, 正太郎

  科学研究費補助金研究成果報告書 2018年

• Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD(要約)

  中鉢, 正太郎

  （慶應義塾大学大学院医学研究科)  2015年

• Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD(要旨)

  中鉢, 正太郎

  （慶應義塾大学大学院医学研究科)  2015年

• Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD(審査報告)

  中鉢, 正太郎

  （慶應義塾大学大学院医学研究科)  2015年

全件表示 >>

総説・解説等 【 表示 ／ 非表示 】

総説・解説等 【 表示 ／ 非表示 】

• A second update on mapping the human genetic architecture of COVID-19

  Kanai M., Andrews S.J., Cordioli M., Stevens C., Neale B.M., Daly M., Ganna A., Pathak G.A., Iwasaki A., Karjalainen J., Mehtonen J., Pirinen M., Chwialkowska K., Trankiem A., Balaconis M.K., Veerapen K., Wolford B.N., Ahmad H.F., von Hohenstaufen Puoti K.A., Boer C., Boua P.R., Butler-Laporte G., Cadilla C.L., Colombo F., Douillard V., Dueker N., Dutta A.K., El-Sherbiny Y.M., Eltoukhy M.M., Esmaeeli S., Faucon A., Fave M.J., Cadenas I.F., Francescatto M., Francioli L., Franke L., Fuentes M., Durán R.G., Cabrero D.G., Harry E.N., Jansen P., Szentpéteri J.L., Kaja E., Kirk C., Kousathanas A., Krieger J.E., Patel S.K., Lemaçon A., Limou S., Lió P., Marouli E., Marttila M.M., Medina-Gómez C., Michaeli Y., Migeotte I., Mondal S., Moreno-Estrada A., Moya L., Nakanishi T., Nasir J., Pasko D., Pearson N.M., Pereira A.C., Priest J., Prijatelj V., Prokic I., Teumer A., Várnai R., Romero-Gómez M., Roos C., Rosenfeld J., Ruolin L., Schulte E.C., Schurmann C., Sedaghati-khayat B., Shaheen D., Shivanathan I., Sipeky C., Sirui Z., Striano P., Tanigawa Y., Remesal A.U., Vadgama N., Vallerga C.L., van der Laan S., Verdugo R.A., Wang Q.S., Wei Z., Zainulabid U.A., Zárate R.N., Auton A., Shelton J.F., Shastri A.J., Weldon C.H., Filshtein-Sonmez T., Coker D., Symons A.

  Nature 621 ( 7977 ) E7 - E26 2023年09月

  ISSN  00280836

  • Access to Document (DOI)

• A rare case of COVID-19 infection with laryngeal involvement

  Asaoka M., Chubachi S., Yamada Y., Fukunaga K.

  BMJ Case Reports 14 ( 6 )  2021年06月

  • Access to Document (DOI)

• Blood eosinophil and neutrophil counts differentially identify frequent exacerbation in patients with COPD with physician-diagnosed asthma and COPD

  Mochimaru T., Chubachi S., Irie H., Sakurai K., Okuzumi S., Sunata K., Masaki K., Miyata J., Nakamura H., Asano K., Fukunaga K.

  Allergology International 70 ( 2 ) 255 - 257 2021年04月

  ISSN  13238930

  • Access to Document (DOI)

研究発表 【 表示 ／ 非表示 】

研究発表 【 表示 ／ 非表示 】

• COPDと間質性肺炎に合併する肺癌の臨床

  中鉢 正太郎

  第37回日本画像医学会, 

  2018年02月

  , 

  シンポジウム・ワークショップ パネル（公募）

• Radiological features of structural basis where cancer develops in COPD lungs

  中鉢 正太郎

  American Thoracic Society 2017 International Conference, 

  2017年05月

  , 

  口頭発表（一般）

• COPDコホート研究追跡期間に新規に発症した肺癌の発症前CTの画像的特徴

  中鉢 正太郎

  第57回日本呼吸器学会学術講演会, 

  2017年04月

  , 

  シンポジウム・ワークショップ パネル（公募）

• Cluster Analysis Based on Comorbidities for Japanese COPD Patients

  中鉢 正太郎

  American Thoracic Society 2016 International Conference, 

  2016年05月

  , 

  口頭発表（一般）

• 全身併存症クラスター解析を用いた日本人COPD患者のフェノタイプ分類

  中鉢 正太郎

  第56回日本呼吸器学会学術講演会, 

  2016年04月

  , 

  シンポジウム・ワークショップ パネル（公募）

全件表示 >>

競争的研究費の研究課題 【 表示 ／ 非表示 】

競争的研究費の研究課題 【 表示 ／ 非表示 】

• 喫煙誘導肺癌及び肺気腫における脂質メディエーターの役割

  2022年04月

  -

  2025年03月

  文部科学省・日本学術振興会, 科学研究費助成事業, 中鉢 正太郎, 基盤研究(C), 補助金,  研究代表者

• 肺気腫及び肺気腫合併肺癌の新規予防薬の探索

  2019年04月

  -

  2022年03月

  文部科学省・日本学術振興会, 科学研究費助成事業, 中鉢　正太郎, 基盤研究（Ｃ）, 補助金,  研究代表者

• 喫煙誘導マウスモデルにおける肺がん発生機序

  2017年04月

  -

  2019年03月

  文部科学省・日本学術振興会, 科学研究費助成事業, 中鉢　正太郎, 若手研究(B), 補助金,  研究代表者

受賞 【 表示 ／ 非表示 】

受賞 【 表示 ／ 非表示 】

• Pneumo Forum最優秀賞

  2022年10月

  受賞区分： 国内学会・会議・シンポジウム等の賞

• 日本呼吸器学会学術部会賞　優秀賞　

  2017年04月, 日本呼吸器学会

• 昭和大学　上條旗が丘賞

  2005年03月, 昭和大学

  　説明を見る

  課外活動で本学の名を宣揚せしめ、かつ人物、学業ともに優秀と認められた学生を卒業時に表彰。

• 昭和大学　上條賞

  2005年03月, 昭和大学

  　説明を見る

  最終学年において、人物が優秀で学業成績が抜群の学生を卒業時に表彰。

担当授業科目 【 表示 ／ 非表示 】

担当授業科目 【 表示 ／ 非表示 】

• 内科学（呼吸器）講義

  2024年度

• 内科学（呼吸器）講義

  2023年度

• 診断学実習

  2023年度

• 内科ケーススタディー

  2023年度

• 内科学（呼吸器）講義

  2022年度

全件表示 >>

担当経験のある授業科目 【 表示 ／ 非表示 】

担当経験のある授業科目 【 表示 ／ 非表示 】

• 診断学実習　ケーススタディー

  慶應義塾

  2018年04月

  -

  2019年03月

  , 

  秋学期, 講義, 専任

• 診断学実習　血液ガス分析

  慶應義塾

  2018年04月

  -

  2019年03月

  , 

  秋学期, 講義, 専任

• 内科学呼吸器　急性呼吸窮迫症候群と急性呼吸不全の管理

  慶應義塾

  2018年04月

  -

  2019年03月

  , 

  秋学期, 講義, 専任

所属学協会 【 表示 ／ 非表示 】

所属学協会 【 表示 ／ 非表示 】

• 日本呼吸器学会

  　

• 日本内科学会

  　

• American thoracic society